Trial Condition(s):
Contraception
Study to assess efficacy and safety of Yasmin in an extended cycle regimen
Bayer Identifier:
91062
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
184
Trial Dates
Phase
4
Could I receive a placebo?
No
Products
Yasmin (EE30/DRSP, BAY86-5131)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
| Locations |
|---|
Trial Design
Prospective, multi-center, open, uncontrolled study to investigate the efficacy, safety and acceptance of SH T 470 FA (Yasmin® [30μg ethinylestradiol and 3mg drospirenone]) in an extended cycle regimen of up to 36 weeks for oral contraception in 200 female volunteers
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
